Tezspire is not a steroid. It is a biologic medication, specifically a monoclonal antibody, that works through an entirely different mechanism than corticosteroids. Tezspire is FDA-approved as an add-on treatment for severe asthma in adults and children aged 12 and older, and one of its key benefits is actually helping patients reduce or stop the steroids they’re already taking.
What Tezspire Actually Is
Tezspire (tezepelumab) belongs to a class of drugs called monoclonal antibodies. These are lab-engineered proteins designed to target one specific molecule in your body. In Tezspire’s case, that target is a signaling protein called thymic stromal lymphopoietin, or TSLP. TSLP is released by cells lining your airways when they detect irritants, allergens, or viruses. It acts like an alarm signal that kicks off a chain of inflammation leading to asthma symptoms.
Tezspire works by binding directly to TSLP and blocking it from reaching its receptor, essentially intercepting the alarm before the inflammatory cascade gets started. This makes it fundamentally different from steroids, which suppress inflammation broadly across multiple pathways. Tezspire is given as a 210 mg injection under the skin once every four weeks.
How Steroids Work Differently
Corticosteroids, whether inhaled or taken as pills, dampen your immune system’s activity across a wide range of pathways. That broad suppression is what makes them effective but also what causes their well-known side effects. Long-term use of oral corticosteroids for asthma is associated with weight gain, acne, excess facial hair, mood swings, high blood pressure, elevated blood sugar, increased infections, bone loss, cataracts, glaucoma, and heart disease.
Tezspire takes a precision approach instead. By blocking a single upstream signal, it prevents inflammation from branching out into multiple pathways rather than trying to tamp down all of them after the fact. This targeted action is why biologics like Tezspire don’t carry the same systemic side effects that make long-term steroid use problematic.
Tezspire’s Side Effect Profile
In clinical trials, Tezspire’s side effects looked remarkably similar to placebo. The most common issue was a sore throat (nasopharyngitis), which occurred in about 12 to 21% of patients depending on the study, roughly the same rate as in people receiving a dummy injection. Upper respiratory infections and headaches were the other notable side effects. Injection-site reactions were rare, occurring in fewer than 2% of patients.
After at least two years of follow-up data, no obvious safety or tolerability concerns emerged. That profile stands in sharp contrast to the long list of complications tied to chronic oral steroid use.
How Tezspire Helps Reduce Steroid Use
Many people with severe asthma depend on daily oral corticosteroids to keep their symptoms under control, despite the toll those drugs take on their bodies. Tezspire can help break that dependence. In the WAYFINDER trial, which specifically studied steroid reduction, about 90% of participants were able to lower their daily steroid dose to 5 mg or less within a year without losing asthma control. Even more striking, roughly half of participants (50.3%) stopped taking oral steroids entirely by week 52.
This steroid-sparing effect is one of the primary reasons doctors prescribe Tezspire. If you’re currently on daily oral steroids for asthma, Tezspire may allow your doctor to gradually taper your dose while the biologic takes over inflammation control through its targeted mechanism.
Where Tezspire Fits Among Asthma Biologics
Tezspire is one of several biologic options now available for severe asthma, and none of them are steroids. The others target different points in the inflammatory pathway: some block a molecule involved in allergic responses (omalizumab), others target proteins that drive a specific type of white blood cell buildup in the airways (mepolizumab, reslizumab, benralizumab), and one blocks two inflammatory signals at once (dupilumab).
What sets Tezspire apart is that it works higher up in the inflammatory chain. Because TSLP triggers multiple downstream pathways, Tezspire can be effective across different types of severe asthma. Clinical trials enrolled patients without requiring any minimum level of specific inflammatory markers, which is unusual for asthma biologics. This means Tezspire may be an option even when other biologics aren’t a clear fit based on your lab results.